financetom
Business
financetom
/
Business
/
MicroStrategy Shares Hit New 52-Week Highs Before Pulling Back: Here's What's Going On
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MicroStrategy Shares Hit New 52-Week Highs Before Pulling Back: Here's What's Going On
Oct 17, 2024 12:24 PM

MicroStrategy Incorporated Inc. shares hit new 52-week highs in early trading Monday before pulling back. Here’s what you need to know.

What To Know: MicroStrategy ( MSTR ) shares reached a 52-week high on Monday, fueled by a surge in Bitcoin prices, but pulled back in the afternoon session. Despite this move lower, the stock remains up about 220% year-to-date (YTD).

The company has long been considered a proxy for Bitcoin due to its significant Bitcoin holdings, which continue to anchor its stock performance. The company is the largest publicly traded holder of Bitcoin, with 252,220BTC as September 20 2024.

What’s Going On: Bitcoin’s price rose more than 4% in the last 24 hours, driving strength across the crypto market and related stocks like MicroStrategy ( MSTR ). Bitcoin is now up nearly 10% over the past month and remains about 12% below its all-time highs.

This crypto rally follows ETF inflows, with approximately $419 million pouring into Bitcoin ETFs last week. Meanwhile, short-Bitcoin products saw outflows of $6.3 million. Political factors may also be in play, as Republican candidates, often seen as more crypto-friendly, gained ground in recent polling.

Analyst Reaction: Additionally, analysts have pointed out that Bitcoin's technical setup could lead to a breakout. Crypto analyst Michaël van de Poppe recently noted that if Bitcoin can break above $64,000, it could trigger a major upward move. Barclays recently raised its price target for MicroStrategy ( MSTR ) from $173 to $225, joining a list of other firms that have lifted targets for the stock in recent weeks.

What Else: MicroStrategy ( MSTR ) has also garnered attention on social media platforms like StockTwits and WallStreetBets. The stock was featured on Benzinga’s "Stock Whisper Index" last week.

MSTR Price Action: MicroStrategy ( MSTR ) shares were down by 4.49% at $203.04 at the time of writing, according to Benzinga Pro.

See Also:

Taiwan Semiconductor Eyes $23B in Q3 Revenue as AI Demand Soars

Image via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Australia sues Microsoft over AI-linked subscription price hikes
Australia sues Microsoft over AI-linked subscription price hikes
Oct 26, 2025
Oct 27 (Reuters) - Australia's competition regulator on Monday sued Microsoft ( MSFT ), accusing it of misleading customers into paying higher prices for Microsoft ( MSFT ) 365 subscriptions after bundling its AI assistant Copilot into personal and family plans. The Australian Competition and Consumer Commission (ACCC) alleged that from October 2024, the technology giant misled about 2.7 million...
Air traffic controller shortages to drag on, US transportation secretary says
Air traffic controller shortages to drag on, US transportation secretary says
Oct 26, 2025
WASHINGTON (Reuters) -U.S. airports reported 22 incidents of air traffic controller shortages on Saturday, Transportation Secretary Sean Duffy said, with more shortages expected to bring more flight delays and cancellations in the days ahead as the government shutdown drags on. According to FlightAware, a flight tracking website, there were more than 5,900 U.S. flight delays by 6 p.m. Eastern Time (2200...
Drug developer MapLight Therapeutics valued at $704.3 million after US IPO
Drug developer MapLight Therapeutics valued at $704.3 million after US IPO
Oct 26, 2025
Oct 26 (Reuters) - Drug developer MapLight Therapeutics, backed by controlling shareholder Novo Holdings, is valued at $704.3 million on Sunday ahead of its Nasdaq debut, as biotech IPOs show signs of revival following a months-long freeze. The Redwood City, California-based company priced the initial public offering at $17 per share. The shares of the company will begin trading on...
Australia takes Microsoft to court, says it misled 2.7 million customers
Australia takes Microsoft to court, says it misled 2.7 million customers
Oct 26, 2025
(Reuters) -Australia's competition watchdog said on Monday said it has filed proceedings in the Federal Court against Microsoft Australia and its parent company Microsoft Corp ( MSFT ) for allegedly misleading about 2.7 million Australian customers. The Australian Competition and Consumer Commission (ACCC) alleges that the company misled customers about subscription options and price increases, after it integrated its AI assistant,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved